A local lymph node assay to analyse immunosuppressive effects of topically applied drugs

European Journal of Pharmacology

Volumn 325, Issue 2-3, 1997, Pages 199-207

  Homey, Bernhard ^a   Schuppe, Hans Christian ^a   Assmann, Till ^a   Vohr, Hans Werner ^b   Lauerma, Antti I ^c   Ruzicka, Thomas ^a   Lehmann, Percy ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b BAYER AG   (Germany)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

FK506; Glucocorticosteroid; Immunosuppression; Local lymph node assay; Tacrolimus; Topical drug

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; MOMETASONE FUROATE; OXAZOLONE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; DERMATITIS, CONTACT; DEXAMETHASONE; DRUG EVALUATION, PRECLINICAL; FEMALE; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENTS; LYMPH NODES; MICE; OXAZOLONE; PREGNADIENEDIOLS; TACROLIMUS;

EID: 0030917599     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00116-7     Document Type: Article

References (52)

1. Aiba, S. and S.I. Katz, 1990, Phenotypic and functional characterization of in vivo-activated LC, J. Immunol. 145, 2791.
2. Aoyama, H., N. Tabata, M. Tanaka, Y. Uesugi and H. Tagami, 1995, Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment [Letter], Br. J. Dermatol. 133, 494.
3. Asensi, V., K. Kimeno, I. Kawamura, M. Sakamoto and K. Nomoto, 1989, Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies, Immunology 68, 204.
4. Auphan, N., J.A. DiDonato, C. Rosette, A. Helmberg and M. Karin, 1995, Immunosuppression by glucocorticosteroids: inhibition of NF-KB activity through induction of IκB synthesis, Science 270, 286.
5. Baker, D., I. Kimber and J.L. Turk, 1989, Antigen-specific regulation of T lymphocyte proliferative responses to contact-sensitizing chemicals in the guinea pig, Cell Immunol. 119, 153.
6. Basketter, D.A., E.W. Scholes, I. Kimber, P.A. Botham, J. Hilton, K. Miller, M.C. Robbins, P.T.C. Harrison and S.J. Waite, 1991, Interlaboratory evaluation of the local lymph node assay with 25 chemicals and comparison with guinea pig test data, Tox. Meth. 1, 30.
7. Basketter, D.A., J.N. Bremmer, P. Buckley, M.E. Kammuller, T. Kawabata, I. Kimber, S.E. Loveless, S. Magda, D.A. Stringer and H.W. Vohr, 1995, Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicology, Food Chem. Toxicol. 33, 239.
8. Bata-Csorgo, Z., C. Hammmerberg, J.J. Voorhees and K.D. Cooper, 1995, Kinetics and regulation of human keratinocyte stem cell growth in short term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T-lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes, J. Clin. Invest. 95, 317.
9. Bos, J.D., M.L. Kapsenberg and J.H. Sillevis Smitt, 1994, Pathogenesis of atopic eczema, Lancet 343, 1338-1341.
10. Coffman, B., 1982, Surface antigen expression and immunoglobulin rearrangement during mouse pre-B cell development, Immunol. Rev. 69, 5.
11. Cooper, K.D., 1994, Atopic dermatitis: recent trends in pathogenesis and therapy, J. Invest. Dermatol. 102, 128.
12. Cronstein, B.N., S.C. Kimmel, R.I. Levin, F. Martiniuk and G. Weissmann, 1992, A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1, Proc. Natl. Acad. Sci. USA 89, 9991.
13. Dearman, R.J., E.W. Scholes, L.S. Ramdin, D.A. Basketter and I. Kimber, 1994, The local lymph node assay: an interlaboratory evaluation of interleukin 6 (IL-6) production by draining lymph node cells, J. Appl. Toxicol. 14, 287.
14. De Maria, R., M.G. Cifone, R. Trotta, M.R. Rippo, C. Festuccia, A. Santoni and R. Testi, 1994, Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors, J. Exp. Med. 180, 1999.
15. Duncan, J.I., 1994, Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporine A, FK506 and rapamycin, J. Invest. Dermatol. 6, 84.
16. Enk, A.M. and S.I. Katz, 1995, Contact hypersensitivity as a model for T-cell activation in skin, J. Invest. Dermatol. 105, 80S.
17. Fehr, B.S., A. Takashima, H. Matsue, J.S. Gerometta, P.R. Bergstresser and P.D. Cruz, 1994, Contact sensitization induces proliferation of heterogenous populations of hapten-specific T cells, Exp. Dermatol. 3, 189.
18. Gleichmann, E., I. Kimber and I.F. Purchase, 1989, Immunotoxicology: suppressive and stimulatory effects of drugs and environmental chemicals on the immune system. A discussion, Arch. Toxicol. 63, 257.
19. Hauser, C., 1990, Cultured epidermal Langerhans cells activate effector T cells for contact hypersensitivity, J. Invest. Dermatol. 95, 440.
20. Homey, B., H.W. Vohr, H.C. Schuppe and P. Kind, 1995a, UV-dependent local lymph node reactions: photoallergy and phototoxicity testing, Curr. Probl. Dermatol. 22, 44.
21. Homey, B., H.W. Vohr, P. Ulrich, A.I. Lauerma, T. Ruzicka, P. Lehmann and H.C. Schuppe, 1995b, Suppression of local lymph node activation by topical FK506 in mice, J. Invest. Dermatol. 105, 487.
22. Homey, B., T. Assmann, H.W. Vohr, A.I. Lauerma, T. Ruzicka, P. Lehmann and H.C. Schuppe, 1996, Topical FK506: suppression of Th1 and Th2 cytokine induction in lymph node cells in vivo, J. Invest. Dermatol. 107, 476.
23. Hope, J.C., R.J. Dearman, I. Kimber and S.J. Hopkins, 1994, The kinetics of cytokine production by draining lymph node cells following primary exposure of mice to chemical allergens, Immunology 83, 250.
24. Kimber, I. and C. Weisenberger, 1989, A murine local lymph node assay for the identification of contact allergens. Assay development and results of an initial validation study, Arch. Toxicol. 63, 274.
25. Kimber, I., R.J. Dearman, E.W. Scholes and D.A. Basketter, 1994, The local lymph node assay: developments and applications, Toxicology 93, 13.
26. Kino, T., H. Hatanaka, S. Miyata, N. Inmura, M. Nishiyama, T. Yajima, T. Goto, M. Kohsaka, H. Aoki and T. Ochiai, 1987, FK596 a novel immunosuppressant isolated from a streptomyces. II. Immunosuppressive effects of FK506 in vitro, J. Antibiot. 40, 1256.
27. Kondo, S., S. Beissert, B. Wang, H. Fujisawa, F. Kooshesh, A. Stratigos, R. Granstein, T.W. Mak and D.N. Sauder, 1996, Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse, J. Invest. Dermatol. 106, 993.
28. Krakauer, T., 1994, A sensitive ELISA for measuring the adhesion of leukocytic cells to human endothelial cells, J. Immunol. Methods 177, 207.
29. Kripke, M.L., C.G. Munn, A. Jeevan, J.-M. Tang and C. Bucana, 1990, Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization, J. Immunol. 145, 2838.
30. Kühn, U., A. Lempertz, J. Knop and D. Becker, 1995, A new method for phenotyping proliferating cell nuclear antigen positive cells using flow cytometry: implications for analysis of immune responses in vivo, J. Immunol. Methods 179, 215.
31. Lauerma, A.I., H.I. Maibach, H. Granlund, P. Erkko, M. Kartamaa and S. Stubb, 1992, Inhibition of contact allergy reactions by topical FK506, Lancet 340, 556.
32. Lauerma, A.I., B.D. Stein, B. Homey, C.H. Lee, E. Bloom and H.I. Maibach, 1994, Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig, Arch. Dermatol. Res. 286, 337.
33. Lemster, B.H., P.B. Carroll, H.R. Rilo, N. Johnson, A. Nikaein and A.W. Thomson, 1995, IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy, Clin. Exp. Immunol. 99, 148.
34. Malek, T.R. and J.D. Ashwell, 1985, Interleukin 2 upregulates expression of its receptor on a T cell clone, J. Exp. Med. 161, 1575.
35. Maurer, T., E.G. Weirich and R. Hess, 1980, The optimization test in guinea pig in relation to other predictive sensitization methods, Toxicology 15, 163.
36. Meingassner, J.G. and A. Stütz, 1992, Immunosuppressive macrolides of type FK506: a novel class of topical agents for treatment of skin diseases? J. Invest. Dermatol. 98, 851.
37. Michel, G., L. Kemeny, B. Homey and T. Ruzicka, 1996, FK506 in the treatment of inflammatory skin disease: promises and perspectives, Immunol. Today 17, 106.
38. Morikawa, K., F. Oseko, S. Morikawa and K. Iwamoto, 1994, Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro, Antimicrob. Agents Chemother. 38, 2643.
39. Nakagawa, H., T. Etoh, Y. Ishibashi, Y. Higaki, M. Kawashima, H. Torii and S. Harada, 1994, Tacrolimus ointment for atopic dermatitis, Lancet 344, 883.
40. Paul, W.E. and J. Ohara, 1987, B-cell stimulatory factor-1/interleukin 4, Annu. Rev. Immunol. 5, 429.
41. Rao, A., 1994, NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes, Immunol. Today 15, 274.
42. Scheinmann, R.I., P.C. Cogswell, A.K. Lofquist and A.S. Baldwin, 1995, Role of transcriptional activation of IκB in mediation of immuno-suppression by glucocorticosteroids, Science 270, 283.
43. Schreiber, S.L. and G.R. Crabtree, 1992, The mechanism of action of cyclosporine A and FK506, Immunol. Today 13, 136.
44. Schulz, B.S., G. Michel, S. Wagner, R. Süss, A Beetz, R.U. Peter, L. Kemeny and T. Ruzicka, 1993, Increased expression of epidermal IL-8 receptor in psoriasis, J. Immunol. 151, 4399.
45. Sigal, N.H. and F.J. Dumont, 1992, Cyclosporine A, FK506 and rapamycin: pharmacological probes of lymphocyte signal transduction, Annu. Rev. Immunol. 10, 519.
46. Swada, S., G. Suzuki, Y. Kawase and F. Takaku, 1987, Novel immuno-suppressive agent FK506: in vitro effects on the cloned T cell activation, J. Immunol. 139, 1797.
47. The European FK506 Multicentre Psoriasis Study Group, 1996, Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study, Arch. Dermatol. 132, 419.
48. Thomsen, A.W., 1990, FK506 enters the clinic, Immunol. Today 11, 35.
49. Walliser, P., C.R. Benzie and J.E. Kay, 1990, Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK506, Immunology 68, 434.
50. Wicker, L.S., R. Boltz, V. Matt, E.A. Nichols, L.B. Peterson and N.H. Sigal, 1990, Suppression of B-cell activation by cyclosporine, FK506 and rapamycin, Eur. J. Immunol. 20, 2277.
51. Yokoyama, W.M., F. Koning, P.J. Kehn, G.M. Pereira, G. Stingl, J.E. Coligan and E.M. Shevach, 1988, Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation, J. Immunol. 141, 369.
52. Zhao, Y., Y. Tozawa, R. Iseki, M. Mukai and M. Iwata, 1995, Calcineurin activation protects T cells from glucocorticoid-induced apoptosis, J. Immunol. 154, 6346.